Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Meiosis II

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterization of response-adapted surgery following neoadjuvant systemic therapy in oral cavity cancer.

Oral oncology·2026

Same author

Expanded Allelic Diversity of Non-Classical HLA Class I and MIC Loci Identified Using Full-Gene Hybrid Capture-Based Next-Generation Sequencing.

HLA·2026

Same author

Proton Therapy for Head and Neck Adenoid Cystic Carcinoma: A Multi-institutional Review.

International journal of particle therapy·2026

Same author

Defining the Role of SABR in Head and Neck Cancer: Results From a Multi-institutional Delphi Consensus.

International journal of radiation oncology, biology, physics·2026

Same author

10th anniversary: The development, implementation, and evaluation of a novel peer-assisted learning (PAL) program.

Currents in pharmacy teaching & learning·2026

Same author

Expanding the Histologic Spectrum of Human Papillomavirus (HPV)-Associated Oropharyngeal Carcinoma: A Retrospective Study of 379 Cases Focusing on Classification, Histologic Features, and their Prognostic Significance.

Head and neck pathology·2026

Same journal

Obstetric Care for Patients With Cognitive Disabilities.

Clinical obstetrics and gynecology·2026

Same journal

Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

Clinical obstetrics and gynecology·2026

Same journal

Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

Clinical obstetrics and gynecology·2026

Same journal

Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

Clinical obstetrics and gynecology·2026

Same journal

Menstrual Management and Contraception for Patients With Disabilities.

Clinical obstetrics and gynecology·2026

Same journal

Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

Clinical obstetrics and gynecology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 12, 2025

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

Published on: February 4, 2015

Second-trimester Abortion.

Vanessa Swantic¹, Darell Hawley², Christopher Zipp²

¹Department of Obstetrics and Gynecology, Morristown Medical Center, Morristown, New Jersey.

Clinical Obstetrics and Gynecology

|November 1, 2023

Summary

This summary is machine-generated.

Second-trimester abortions, though a small percentage, may increase due to access restrictions. This guide covers medication and procedural abortions, emphasizing evidence-based postabortion care for healthcare providers.

More Related Videos

Double In Utero Electroporation to Target Temporally and Spatially Separated Cell Populations

Double In Utero Electroporation to Target Temporally and Spatially Separated Cell Populations

Published on: June 14, 2020

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs

Published on: December 22, 2023

Related Experiment Videos

Last Updated: Jul 12, 2025

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

Published on: February 4, 2015

Double In Utero Electroporation to Target Temporally and Spatially Separated Cell Populations

Double In Utero Electroporation to Target Temporally and Spatially Separated Cell Populations

Published on: June 14, 2020

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs

Published on: December 22, 2023

Area of Science:

Reproductive Health
Obstetrics and Gynecology

Background:

In 2019, 7% of abortions occurred after 13 weeks gestation.
Anticipated increase in second-trimester abortions due to nationwide access restrictions.
Second-trimester abortions are performed via medication or surgical procedures.

Purpose of the Study:

To provide foundational knowledge for healthcare practitioners.
To outline care for individuals undergoing second-trimester abortion.
To support evidence-based postabortion care.

Main Methods:

Review of current medical practices for second-trimester abortion.
Synthesis of evidence-based guidelines for postabortion care.
Educational resource development for healthcare providers.

Main Results:

Comprehensive overview of medication and procedural abortion methods.
Detailed recommendations for pre-, intra-, and post-procedural care.
Emphasis on patient-centered, evidence-based management.

Conclusions:

Healthcare providers need updated knowledge on second-trimester abortion care.
Standardized, evidence-based protocols are crucial for optimal patient outcomes.
Preparedness for increased demand in second-trimester abortion services is essential.